Impact of antiretroviral therapy on lung immunology and inflammation

Clin Chest Med. 2013 Jun;34(2):155-64. doi: 10.1016/j.ccm.2013.01.004. Epub 2013 Apr 8.

Abstract

Human immunodeficiency virus (HIV) infection causes profound changes in the lung compartment characterized by macrophage and lymphocyte activation, secretion of proinflammatory cytokines and chemokines, and accumulation of CD8 T cells in the alveolar space, leading to lymphocytic alveolitis. Because many of the changes seen in the lung can be attributed to the direct effect of HIV on immune cells, therapy to reduce the HIV burden should have significant beneficial effects. Indeed, antiretroviral therapy rapidly reduces the viral burden in the lung, number of CD8 T cells in the alveolar space, and amount of proinflammatory cytokines and chemokines in bronchoalveolar lavage.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Anti-Retroviral Agents / pharmacology*
  • Anti-Retroviral Agents / therapeutic use
  • Cytokines / immunology
  • HIV Infections / drug therapy*
  • HIV Infections / immunology
  • HIV Infections / virology
  • Humans
  • Inflammation / immunology
  • Lung / immunology*
  • Lung / virology
  • Lymphocyte Activation / drug effects
  • T-Lymphocytes / immunology
  • Viral Load

Substances

  • Anti-Retroviral Agents
  • Cytokines